BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15509162)

  • 1. Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices.
    Li LS; Rader C; Matsushita M; Das S; Barbas CF; Lerner RA; Sinha SC
    J Med Chem; 2004 Nov; 47(23):5630-40. PubMed ID: 15509162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient chemical approach to bispecific antibodies and antibodies of high valency.
    Gavrilyuk JI; Wuellner U; Salahuddin S; Goswami RK; Sinha SC; Barbas CF
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3716-20. PubMed ID: 19497743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.
    Trikha M; Zhou Z; Nemeth JA; Chen Q; Sharp C; Emmell E; Giles-Komar J; Nakada MT
    Int J Cancer; 2004 Jun; 110(3):326-35. PubMed ID: 15095296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
    Popkov M; Rader C; Gonzalez B; Sinha SC; Barbas CF
    Int J Cancer; 2006 Sep; 119(5):1194-207. PubMed ID: 16570283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin-targeted delivery into cancer cells of a Pt(IV) pro-drug through conjugation to RGD-containing peptides.
    Massaguer A; González-Cantó A; Escribano E; Barrabés S; Artigas G; Moreno V; Marchán V
    Dalton Trans; 2015 Jan; 44(1):202-12. PubMed ID: 25369773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of integrin alpha(v)beta3-targeting Ab 38C2 constructs.
    Sinha SC; Das S; Li LS; Lerner RA; Barbas CF
    Nat Protoc; 2007; 2(2):449-56. PubMed ID: 17406606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy.
    Rader C; Turner JM; Heine A; Shabat D; Sinha SC; Wilson IA; Lerner RA; Barbas CF
    J Mol Biol; 2003 Sep; 332(4):889-99. PubMed ID: 12972259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic RGD peptidomimetics containing bifunctional diketopiperazine scaffolds as new potent integrin ligands.
    Marchini M; Mingozzi M; Colombo R; Guzzetti I; Belvisi L; Vasile F; Potenza D; Piarulli U; Arosio D; Gennari C
    Chemistry; 2012 May; 18(20):6195-207. PubMed ID: 22517378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grafting aminocyclopentane carboxylic acids onto the RGD tripeptide sequence generates low nanomolar alphaVbeta3/alphaVbeta5 integrin dual binders.
    Casiraghi G; Rassu G; Auzzas L; Burreddu P; Gaetani E; Battistini L; Zanardi F; Curti C; Nicastro G; Belvisi L; Motto I; Castorina M; Giannini G; Pisano C
    J Med Chem; 2005 Dec; 48(24):7675-87. PubMed ID: 16302808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Click-chemistry-derived triazole ligands of arginine-glycine-aspartate (RGD) integrins with a broad capacity to inhibit adhesion of melanoma cells and both in vitro and in vivo angiogenesis.
    Trabocchi A; Menchi G; Cini N; Bianchini F; Raspanti S; Bottoncetti A; Pupi A; Calorini L; Guarna A
    J Med Chem; 2010 Oct; 53(19):7119-28. PubMed ID: 20809642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple catalytic aldolase antibodies suitable for chemical programming.
    Goswami RK; Huang ZZ; Forsyth JS; Felding-Habermann B; Sinha SC
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3821-4. PubMed ID: 19428247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis of the Differential Binding of Engineered Knottins to Integrins αVβ3 and α5β1.
    Van Agthoven JF; Shams H; Cochran FV; Alonso JL; Kintzing JR; Garakani K; Adair BD; Xiong JP; Mofrad MRK; Cochran JR; Arnaout MA
    Structure; 2019 Sep; 27(9):1443-1451.e6. PubMed ID: 31353240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
    Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A
    Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule integrin antagonists in cancer therapy.
    Paolillo M; Russo MA; Serra M; Colombo L; Schinelli S
    Mini Rev Med Chem; 2009 Oct; 9(12):1439-46. PubMed ID: 19929817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface overexpression of alphavbeta5 integrin impedes alphavbeta3-mediated migration of the human ovarian adenocarcinoma cell line IGROV1.
    Maubant S; Leroy-Dudal J; Carreiras F; Deslandes E; Duigou F; Staedel C; Gauduchon P
    Cell Biol Int; 2007 Feb; 31(2):109-18. PubMed ID: 17074516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of new conformationally biased integrin ligands based on a tetrahydroazoninone scaffold.
    Banfi L; Basso A; Damonte G; De Pellegrini F; Galatini A; Guanti G; Monfardini I; Riva R; Scapolla C
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1341-5. PubMed ID: 17169558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human integrin alphavbeta5: homology modeling and ligand binding.
    Marinelli L; Gottschalk KE; Meyer A; Novellino E; Kessler H
    J Med Chem; 2004 Aug; 47(17):4166-77. PubMed ID: 15293989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection.
    Veettil MV; Sadagopan S; Sharma-Walia N; Wang FZ; Raghu H; Varga L; Chandran B
    J Virol; 2008 Dec; 82(24):12126-44. PubMed ID: 18829766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered fibronectin type III domain with a RGDWXE sequence binds with enhanced affinity and specificity to human alphavbeta3 integrin.
    Richards J; Miller M; Abend J; Koide A; Koide S; Dewhurst S
    J Mol Biol; 2003 Mar; 326(5):1475-88. PubMed ID: 12595259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.